Adalimumab
Adalimumab is a biologic medication classified as a TNF (tumor necrosis factor) inhibitor. It is a recombinant human monoclonal antibody that targets and neutralizes TNF-alpha, a protein involved in systemic inflammation. It is administered via subcutaneous injection and is used to treat a variety of autoimmune and inflammatory conditions. Reference standards of Adalimumab API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Adalimumab
[catalogue_number] => PA PEP 003037
[category_ids] => ,114,
[chemical_name] =>
[weight] => NA
[form] => NA
[cas] => 331731-18-1
[pslug] => 331731-18-1-adalimumab-papep003037
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
